pemphigus vulgaris
pemphigus vulgaris
Explore linked clinical trials. Standard reference: MONDO:00082196 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Rituximab With Corticosteroids Versus Corticosteroids Plus Azathioprine for Moderate-to-Severe Pemphigus Vulgaris | Skin and Connective Tissue Diseases, autoimmune disease, immune system disorder, pemphigus, pemphigus vulgaris, skin disorder, vesiculobullous skin disease | Not yet recruiting | Early phase 1 | 2026-08-18 | NCT07769333 | |
| CD19 CAR-T Therapy for Refractory Pemphigus Vulgaris | Skin and Connective Tissue Diseases, autoimmune disease, immune system disorder, pemphigus, pemphigus vulgaris, skin disorder, vesiculobullous skin disease | Recruiting | Not applicable | 2026-07-02 | NCT07681388 | |
| A Phase 1/2, Open-label, Safety and Dosing Study of Autologous CART Cells (Desmoglein 3 Chimeric Autoantibody Receptor T Cells [DSG3-CAART] or CD19-specific Chimeric Antigen Receptor T Cells [CABA-201]) in Subjects With Active, Pemphigus Vulgaris (RESET-PV) | Skin and Connective Tissue Diseases, autoimmune disease, immune system disorder, pemphigus, pemphigus vulgaris, skin disorder, vesiculobullous skin disease | Recruiting | Phase 1 / Phase 2 | 2026-05-29 | NCT04422912 | |
| Autoimmune Blistering Diseases Study | Skin and Connective Tissue Diseases, autoimmune disease, bullous pemphigoid, immune system disorder, pemphigus, pemphigus foliaceus, pemphigus vulgaris, skin disorder, vesiculobullous skin disease | Recruiting | Not stated | 2026-03-30 | NCT02753777 | |
| Low-level Laser Therapy on Oral Pemphigus Vulgaris Patients. | Skin and Connective Tissue Diseases, autoimmune disease, immune system disorder, pemphigus, pemphigus vulgaris, skin disorder, vesiculobullous skin disease | Not yet recruiting | Not applicable | 2025-05-14 | NCT06971172 | |
| Open-label Single-Center Study to Evaluate the Safety and Efficacy of Combining Rituximab and AB-101 in B-cell Associated Autoimmune Diseases. | Skin and Connective Tissue Diseases, anti-neutrophil cytoplasmic antibody-associated vasculitis, arthritic joint disease, arthropathy, autoimmune disease, cardiovascular disorder, connective tissue disorder, granulomatosis with polyangiitis, immune system disorder, interstitial lung disease, lung disorder, musculoskeletal system disorder, necrotizing vasculitis, pemphigus, pemphigus vulgaris, respiratory system disorder, rheumatic disorder, rheumatoid arthritis, skin disorder, skin vascular disease, systemic lupus erythematosus, vascular disorder, vasculitis, vesiculobullous skin disease | Recruiting | Phase 1 | 2024-09-03 | NCT06581562 |